Tsaur I, Haferkamp A
Klinik für Urologie und Kinderurologie, Universitätsklinik, Johann Wolfgang Goethe-Universität, Theodor-Stern-Kai 7, Frankfurt am Main, Germany.
Urologe A. 2011 Sep;50 Suppl 1:216-8. doi: 10.1007/s00120-011-2676-6.
This overview presents new insights into renal cell carcinoma (RCC). The search for new target structures for targeted therapy as well as diagnostic and prognostic markers continues to remain a desirable area of research. Investigations are focusing on the use of well-established and new therapeutic agents for metastatic RCC and an increasingly liberal indication for organ-sparing surgery for renal tumors. The response to systemic treatment in metastatic RCC is also being evaluated in defined subpopulations.
本综述介绍了肾细胞癌（RCC）的新见解。寻找靶向治疗的新靶点结构以及诊断和预后标志物仍然是一个理想的研究领域。研究重点在于将成熟的和新型治疗药物用于转移性RCC，以及对肾肿瘤采取越来越宽松的保留器官手术指征。转移性RCC对全身治疗的反应也正在特定亚群中进行评估。
